Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway by Hubbard, G P et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quercetin inhibits collagen-stimulated platelet activation through
inhibition of multiple components of the glycoprotein VI
signaling pathway
Citation for published version:
Hubbard, GP, Stevens, JM, Cicmil, M, Sage, T, Jordan, PA, Williams, CM, Lovegrove, JA & Gibbins, JM
2003, 'Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of
the glycoprotein VI signaling pathway' Journal of Thrombosis and Haemostasis, vol 1, no. 5, pp. 1079-88.,
10.1046/j.1538-7836.2003.00212.x
Digital Object Identifier (DOI):
10.1046/j.1538-7836.2003.00212.x
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher final version (usually the publisher pdf)
Published In:
Journal of Thrombosis and Haemostasis
Publisher Rights Statement:
Copyright 2003 International Society on Thrombosis and Haemostasis
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
ORIGINAL ARTICLE
Quercetin inhibits collagen-stimulated platelet activation
through inhibition of multiple components of the
glycoprotein VI signaling pathway
G . P . H U B B A R D , y J . M . S T E V E N S , y M . C I C MI L , y T . S A G E , y P . A . J O R D A N , y C . M . W I L L I A M S , 
J . A . L O V E G R O V E  and J. M. Gibbinsy
School of Food Biosciences and ySchool of Animal and Microbial Sciences, University of Reading, Reading, UK
Summary. Background: The regulation of platelet function by
pharmacological agents that modulate platelet signaling has
proven a successful approach to the prevention of thrombosis. A
variety of molecules present in the diet have been shown to
inhibit platelet activation, including the antioxidant quercetin.
Objectives: In this report we investigate the molecular mechan-
isms through which quercetin inhibits collagen-stimulated pla-
telet aggregation. Methods: The effect of quercetin on platelet
aggregation, intracellular calcium release, whole cell tyrosine
phosphorylation and intracellular signaling events including
tyrosine phosphorylation and kinase activity of proteins in-
volved in the collagen-stimulated glycoprotein (GP) signaling
pathway were investigated. Results: We report that quercetin
inhibits collagen-stimulated whole cell protein tyrosine phos-
phorylation and intracellular mobilization of calcium, in a con-
centration-dependent manner. Quercetin was also found to inhibit
various events in signaling generated by the collagen receptor
GPVI. This includes collagen-stimulated tyrosine phosphoryla-
tion of the Fc receptor g-chain, Syk, LATand phospholipase Cg2.
Inhibition of phosphorylation of the Fc receptor g-chain suggests
thatquercetin inhibitsearlysignalingeventsfollowingstimulation
of platelets with collagen. The activity of the kinases that phos-
phorylate the Fc receptor g-chain, Fyn and Lyn, as well as the
tyrosine kinase Syk and phosphoinositide 3-kinase was also
inhibited by quercetin in a concentration-dependent manner, both
in whole cells and in isolation. Conclusions: The present results
provide a molecular basis for the inhibition by quercetin of
collagen-stimulated platelet activation, through inhibitionof mul-
tiplecomponentsof theGPVIsignalingpathway,andmaybeginto
explain the proposed health benefits of high quercetin intake.
Keywords: collagen, GPVI, platelets, quercetin.
Introduction
Platelets play a pivotal role in both health and disease, through
their central involvement in hemostasis and thrombosis. When
blood vessels become damaged, subendothelial macromole-
cules such as collagen and thrombin, which are exposed or
generated at the site of damage, stimulate platelet activation and
the initiation of hemostasis. Collagen supports the adhesion of
platelets to the site of injury via von Willebrand factor (VWF) as
well as glycoprotein VI (GPVI) and integrin a2b1 [1,2]. The
binding of collagen to GPVI results in receptor clustering and
thereby stimulates the tyrosine phosphorylation of specific
tyrosine residues within an associated transmembrane protein,
the Fc receptor g-chain (FcR g-chain) [3,4]. This leads to the
recruitment of signaling proteins such as the tyrosine kinase Syk
and phosphoinositide 3-kinase (PI 3-kinase) leading to the
activation of several signaling pathways [4–6]. This results
in platelet shape change and spreading, and the release or
secretion of proactivatory substances that activate and recruit
platelets to the developing thrombus.
Platelets are recognized to play important roles in aspects of
cardiovascular disease, most notably through their critical
involvement in causing thrombosis. In addition, platelet accu-
mulation in the arterial wall at sites of endothelial injury has
been suggested to be a key event in the initiation and propaga-
tion of atherosclerotic lesions [7].
The modulation of platelet activity using specific pharma-
cological agents has proven to be a successful strategy for the
prevention of thrombosis. Platelet activation may also be in-
hibited by a number of dietary components including alcohol
[8], some dietary fats [9] and antioxidants [10]. The relationship
between diet, platelet function and cardiovascular disease is not
fully understood.
A dietary antioxidant that has received attention with regard
to its effects on platelet function is the polyphenolic compound
quercetin (3,30,40,5,7-pentahydroxyflavone) [11], found in high
concentrations in onions, apples, wine and tea [11]. A high
dietary intake of this compound and others of the same family
has been correlated with a decreased risk of coronary heart
disease [12]. This is believed to be mediated through a wide
spectrum of pharmacological effects. Quercetin has been shown
to be able to inhibit low-density lipoprotein oxidation in vitro
[13] and cause vasodilation in rat aortic strips [14]. Further-
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more, quercetin has been shown in vitro to inhibit platelet
aggregation [15–17]. However, a mechanism for this action
has not been elucidated. In this study we have investigated the
effects of quercetin on collagen-stimulated platelet activation
and signaling. We show that quercetin inhibits the activity of a
number of critical molecules involved in the GPVI collagen
receptor-stimulated signaling pathway in platelets.
Experimental procedures
Materials
Quercetin dihydrate was solubilized in dimethylsulfoxide
(DMSO) both purchased from Sigma (Poole, UK). Horm-
Chemie collagen (collagen-fibres from equine tendons) was
purchased from Nycomed (Munich, Germany). Anti-phospho-
tyrosine monoclonal antibody (4G10) and anti-p85 phosphoi-
nositide 3-kinase were from Upstate Biotechnology (TCS
Biologicals, Botolph Claydon, Bucks, UK). Anti-Syk (N-19),
anti-Syk (LR), anti-LAT, anti-PLCg2, anti-Fyn and anti-Lyn
polyclonal antibodies were purchased from Santa Cruz Bio-
technology (Autogen Bioclear UK Ltd, Calne, Wilts, UK), and
anti-Lyn (clone 42) monoclonal antibody was purchased from
Transduction Laboratories (Lexington, KY, USA). Horseradish
peroxidase (HRP)-conjugated secondary antibodies, the
enhanced chemiluminescence detection system and the
g-32P-ATP were purchased from Amersham Biosciences Bio-
tech (Little Chalfont, UK). L-a-phosphoinositide and bovine
thrombin were from Sigma. Fura-2 AM was from Molecular
Probes (Cambridge Bioscience, Cambridge, UK). All other
reagents were from previously described sources [18,19].
Preparation and stimulation of platelets
Human platelets from healthy aspirin-free volunteers were
prepared on the day of the experiment by differential centrifu-
gation as described previously [5] and suspended in modified
Tyrodes-HEPES buffer (134 mM NaCl, 0.34 mM Na2HPO4,
2.9 mM KCl, 12 mM NaHCO3, 20 mM HEPES, 5 mM glucose,
1 mM MgCl2, pH 7.3) to a density of 2 108 cells mL1 for
aggregation experiments. For protein precipitation experiments,
platelets were suspended at 8 108 cells mL1 in buffer con-
taining 1 mM EGTA to prevent aggregation. Stimulation of
platelets (450mL) with collagen (50mL) was performed at
37 8C in an optical platelet aggregometer (Chrono-log Corp.,
Havertown, PA, USA) with continuous stirring (1200 r.p.m.).
Platelets were incubated with quercetin dissolved in DMSO
(1 mL) or with DMSO alone (1 mL) (0.2% v/v) for 5 min (after
10 s stirring) followed by stimulation with collagen for 90 s. No
changes in pH after quercetin or collagen treatment were
detected in platelet suspensions.
Immunoprecipitation studies
Platelet stimulation was terminated by the addition of an equal
volume of ice-cold NP40 lysis buffer [2% (v/v) Nonidet P40,
20 mM Tris, 300 mM NaCl, 10 mM EDTA, 1 mM phenylmethyl-
sulfonyl fluoride, 2 mM Na3VO4, 10 mg mL
1 leupeptin,
10mg mL1 aprotonin, 1mg mL1 pepstatin A, pH 7.3]. Deter-
gent-insoluble debris was removed and the lysates were pre-
cleared by mixing with protein A-Sepharose (PAS) for 1 h at
4 8C (60mL of a 50% (w/v) suspension in Tris-buffered saline–
Tween [TBS–T; 20 mM Tris, 137 mM NaCl, 0.1% (v/v) Tween
20, pH 7.6]. PAS was removed from the lysates before the
addition of antibody (1mg mL1). Following rotation for 1 h at
4 8C, 60mL PAS suspension were added to each sample and
rotated for a further 1 h at 4 8C before washing the Sepharose
pellet in lysis buffer and the addition of Laemmli sample-
treatment buffer. Proteins were separated by SDS–PAGE under
reducing conditions using 10% gels and transferred to poly-
vinylidene difluoride (PVDF) membranes by semidry Western
blotting.
Fusion protein precipitation studies
A GST fusion protein containing the tandem SH2 domains of
Syk (GST-SYK-SH2) was expressed and purified as described
elsewhere [20], and bound to glutathione-agarose. Precipitation
of platelet proteins with the fusion construct was performed as
described previously [3]. Precipitated proteins were separated
by SDS–PAGE under reducing conditions, and transferred to
polyvinylidene difluoride membranes.
Immunoblotting
Membranes were blocked by incubation in 10% (w/v) bovine
serum albumin (BSA) dissolved in TBS–T. Primary and sec-
ondary antibodies were diluted in TBS–T containing 2% (w/v)
BSA, and incubated with membranes for 1 h at room tempera-
ture with rotation. Blots were washed for 2 h in TBS–T follow-
ing each incubation with antibodies and then developed using
an enhanced chemiluminescence detection system. Primary
antibodies were used at a concentration of 1mg mL1 [antipho-
sphotyrosine 4G10; anti-Syk (N-19); anti-Fyn; anti-Lyn (clone
42); anti-PLCg2; anti-LAT; anti-p85 phosphatidylinositol 3-
kinase] and horseradish peroxide (HRP)-conjugated secondary
antibodies (antirabbit-IgG-HRP; antimouse-IgG-HRP) were
diluted 1 : 10000.
Measurement of [Ca2þ]i by spectrofluorimetry
Washed human platelets (as above) were incubated at
2 109 cells mL1 in calcium-free Tyrodes-HEPES buffer with
3mM Fura-2 AM for 45 min. Platelets were washed once and
resuspended at 2 108 cells mL1 in modified Tyrodes-HEPES
buffer. Platelets (450mL) were incubated with quercetin dis-
solved in DMSO (1 mL) or DMSO alone (0.2% v/v) for 5 min
and then stimulated with collagen (50mL) with constant stirring
at 37 8C in a luminescence spectrophotometer (LS-50B; Perkin
Elmer, Beaconsfield, Bucks, UK) with excitation wavelengths
of 340 nm and 380 nm. Fluorescence emission was measured at
a wavelength of 510 nm. The ratio of emission values (340/
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380 nm) was calculated and converted to calcium concentration
using FLWinLab software (Perkin Elmer) using the equation
[Ca2þ]i¼Kd (RRmin)/(RmaxR) SFB [where R is emis-
sion ratio value (340/380 nm)]. Rmax, the maximum 340/380
ratio, was determined by lyzing platelets with NP40 immuno-
precipitation lysis buffer in the presence of 1 mM CaCl2. The
Rmin 340/380 nm ratio was determined by addition of 2 mM
EGTA. Kd is the dissociation constant of the Fura-2/Ca
2þ
complex (224 nM) and SFB is the fluorescence ratio at 340/
380 nm of Rmin and Rmax.
Assay of in vitro kinase activity
Syk, Fyn or Lyn were immunoprecipitated and assayed for kinase
activity whilst immobilizedon protein-A Sepharose following the
final wash step. Immunoprecipitates were suspended in assay
buffer (105 mM NaCl, 20 mM HEPES pH 7.4, 5 mM MnCl2, 5 mM
MgCl2, 2 mM NaF, 1 mM Na3VO4, 10mM ATP together with 5mCi
ofg-32P-ATP per reaction) and incubated at 30 8C for 20 min prior
to termination by the addition of Laemmli SDS–PAGE sample
treatment buffer. Proteins were separated by SDS–PAGE, trans-
ferred to PVDF membranes and exposed to storage phosphor
screens to detect the incorporation of 32P into proteins present in
the immunoprecipitated kinase (i.e. autophosphorylation). In
some assays platelets werenot incubated withquercetin orDMSO
prior to stimulation. Quercetin or DMSO was instead added to the
assay mixture prior to addition to the immunoprecipitate to
investigatepotentialdirecteffectsofquercetinonenzymeactivity.
Phosphoinositide 3-kinase assay
Phosphoinositide 3-kinase (PI 3-kinase) was immunoprecipi-
tated from platelets using an anti-p85 (regulatory subunit)
antibody, and assayed for kinase activity while immobilized
on protein-A Sepharose. PI 3-kinase activity was measured as
described elsewhere [21]. Briefly, the immune complex pellet
was washed twice in kinase buffer (50 mM HEPES pH 7.4,
100 mM NaCl, 1 mM DTT), resuspended in kinase buffer with
L-a-phosphoinositide vesicles (200 mg mL1 in 5 mM HEPES
pH 7.4) and incubated for 20 min at 4 8C. The enzyme reaction
was initiated by adding ATP-mix (5 mM MgCl2, 100mM ATP
together with 1mCi g-32P-ATP per reaction). The reaction was
incubated for 10 min at 30 8C and terminated by addition of 1 M
HCl. Lipids were extracted and separated by thin layer chro-
matography (TLC). Products were visualized by exposing TLC
plates to phosphor screens for 2–6 h. The reaction products were
quantified using a phosphorimager with ImageQuant software
(Amersham Biosciences). In some assays platelets were not
incubated with quercetin or DMSO prior to stimulation. Quer-
cetin or DMSO was instead added to the assay mixture prior to
addition to the immunoprecipitate.
Statistical analysis
IC50 values were calculated using Prism for Windows version
2.0 (Graphpad Inc., San Diego, CA, USA) using non-linear
regression. Graphs were plotted with a sigmoidal curve, and
variable Hill slope with 100% and 0% inhibition constants.
Paired t-tests were performed using SPSS 10.0 for windows
(SPSS, Chicago, IL, USA). Results are presented as mean
values with standard error of mean and P-value 0.05 con-
sidered significant.
Results
Quercetin inhibits collagen-stimulated platelet aggregation
Quercetin has been shown previously to inhibit platelet aggre-
gation in both washed platelets and platelet-rich plasma, with a
number of different agonists including collagen, thrombin, ADP
and arachidonic acid. Beretz et al. (1982) [15] used collagen as
an agonist at 2.5mg mL1 and reported an IC50 for quercetin of
55 mM. However, Landolfi et al. (1984) [16] stimulated platelets
with arachidonic acid (150mM) and reported an IC50 for quer-
cetin of 18 mM. It was necessary to confirm this inhibitory action
in our experimental system.
Platelets were incubated with quercetin or solvent alone for
5 min and then stimulated with collagen for 90 s. Quercetin was
observed to cause a concentration-dependent inhibition of
platelet aggregation (not shown). In Table 1 IC50 values for
quercetin-mediated inhibition of platelet aggregation at differ-
ent concentrations of collagen (0.5, 1, 2, 3, 4 and 5mg mL1) are
given. Results are derived from three separate experiments.
DMSO (0.2% v/v) was used as solvent control and had no effect
on platelet aggregation at this concentration. The IC50 values
obtained were dependent on the concentration of collagen
used, where lower concentrations of quercetin were required
to cause 50% inhibition of platelet aggregation at lower con-
centrations of collagen. The IC50 value for the highest con-
centration of collagen used (5 mg mL1), is lower than
previously reported (IC50: 8.7mM) [15,16]. Quercetin also in-
hibited platelet aggregation in response to other agonists.
However, this effect was less potent in comparison with the
inhibitory effect of quercetin on collagen-stimulated platelet
aggregation with notably higher IC50 values, i.e. thrombin
0.1 IU mL1, IC50 27.6 mM (	 1.04).
Table 1 IC50 values for the inhibition of platelet aggregation by quercetin
with varying concentrations of collagen
Collagen
mg mL1
IC50 (quercetin)
mM (n¼ 3)	 SEM
5 8.69	 1.05
4 6.47	 1.09
3 4.93	 1.12
2 4.87	 1.11
1 3.02	 1.05
0.5 2.37	 1.03
Washed platelets were incubated with quercetin or solvent control
for 5 min and then stimulated with collagen for 90 s. The inhibition of
platelet aggregation was determined in comparison with control and
IC50 values were calculated.
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Quercetin inhibits collagen-stimulated mobilization of
calcium from intracellular stores in a concentration-dependent
manner
Stimulation of the collagen receptor GPVI leads to rapid
intracellular mobilization of calcium, which is essential for
platelet secretion and aggregation [22]. To investigate the effect
of quercetin on the intracellular mobilization of calcium stores,
calcium levels were measured fluorometrically using the cal-
cium-sensitive dye, Fura-2 AM. Experiments were performed
in the presence of 2 mM EGTA to prevent the influx of extra-
cellular calcium. Fura-2 AM-loaded platelets were preincu-
bated with quercetin or solvent alone for 5 min and then
stimulated with collagen (5 mg mL1). Stimulation of platelets
with collagen resulted in a rapid increase in intracellular
calcium concentration (Fig. 1A). Quercetin caused a concen-
tration-dependent decrease in collagen-stimulated intracellular
calcium release. This inhibitory response is within the same
concentration range as that shown in Table 1 (IC50¼ 9.4 mM) for
aggregation at this concentration of collagen. Mean peak
calcium concentration from separate experiments (n¼ 3,	
SEM) as a percentage of maximal response is shown in Fig. 1B.
Collagen-stimulated platelet protein tyrosine phosphorylation
is inhibited by quercetin
Given the marked effect of quercetin on platelet aggregation, we
investigated the effect of quercetin on collagen-stimulated
signal transduction. Stimulation of platelets with collagen
results in the activation of a tyrosine kinase-dependent signaling
pathway [3,4,6]. Consequently, platelet activation with collagen
is accompanied by tyrosine phosphorylation of multiple platelet
proteins. The effect of quercetin on levels of protein tyrosine
phosphorylation was examined in platelet whole cell lysates
(Fig. 2). Consistent with previous reports [23] collagen
(25mg mL1) induced an increase in the protein tyrosine phos-
phorylation of a number of platelet proteins in comparison with
basal levels. Pretreatment of platelets with quercetin for 5 min
prior to stimulation with collagen (25mg mL1) resulted in a
concentration-dependent inhibition of protein tyrosine phos-
phorylation. In these and the following experiments, platelets
were stimulated under non-aggregating conditions due to the
inclusion of EGTA (1 mM), which chelates calcium, in order to
ensure the study of primary signaling events via collagen, rather
than secondary stimulation following secretion and aggrega-
tion. This standard approach to study platelet signaling, also
holds the advantage that aggregation-dependent relocation of
signaling proteins to insoluble cytoskeletal fractions is pre-
vented. This facilitates immunoprecipitation of equivalent
levels of signaling proteins from resting and activated platelets,
which is essential for the experiments described below. Due to
the reduced levels of positive feedback signaling as a result of
EGTA treatment it is necessary to increase collagen concentra-
tions to 25 mg mL1 in order to observe a substantial increase in
protein tyrosine phosphorylation. Quercetin concentrations
used were increased proportionately (5-fold) when compared
Fig. 1. Quercetin inhibits collagen-stimulated
mobilization of calcium from intracellular stores
in a concentration-dependent manner. Fura-2
AM-loaded platelets were incubated with
quercetin or solvent control for 5 min and then
stimulated with collagen (5mg mL1) for 200 s.
The mobilization of calcium was measured by
spectrofluorimetry as described in Methods. (A)
A representative set of calcium responses
(calcium concentration [CA2þ] (nM) vs. time [s])
following preincubation with solvent control
(DMSO) or quercetin (5–20mM) (arrow indicates
the addition of agonist). (B) Mean peak calcium
concentration data shown as a percentage
response compared with control for a range of
quercetin concentrations (n¼ 3,	SEM,
P 0.005).
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with the concentrations used in Fig. 1. The addition of relatively
large volumes of collagen in acid buffer did not exceed the
buffering capacity of the modified Tyrodes buffer and the pH
remained at 7.3.
Quercetin inhibits the tyrosine phosphorylation of multiple
components of the GPVI signaling pathway
To examine the mechanism through which quercetin inhibits
collagen receptor-mediated signaling we examined the effect of
this compound on the tyrosine phosphorylation of a number of
components of the collagen-signaling pathway. Activation of
the GPVI collagen receptor results in tyrosine phosphorylation
of the associated receptor-complex protein, the FcR g-chain
[3,4]. The effect of quercetin on the level of tyrosine phosphor-
ylation of this protein following stimulation with collagen was
therefore examined. Quercetin caused the level of collagen-
stimulated tyrosine phosphorylation of the FcR g-chain to
become diminished in a concentration-dependent manner
(Fig. 3A). A substantial decrease in tyrosine phosphorylation
of the FcR g-chain was observed on treatment with 25 mM
quercetin, and was completely inhibited at a concentration of
150mM. This indicates that quercetin is able to inhibit very early
signaling events in the collagen signaling pathway. To confirm
this, molecules that had been shown to lie downstream of the
FcR g-chain were also examined. As may be anticipated,
collagen-stimulated tyrosine phosphorylation of the non-recep-
tor tyrosine kinase Syk was also inhibited by quercetin in a
concentration-dependent manner (Fig. 3B) with a similar profile
to that of the FcR g-chain. Activation of Syk following its
association with the activated receptor complex results in
tyrosine phosphorylation of the transmembrane adapter protein
LAT [5], which in turn leads to the recruitment of phospholipase
Cg2 (PLCg2) [24]. We therefore also investigated the effect of
quercetin on collagen-stimulated tyrosine phosphorylation of
LAT (Fig. 3C) and PLCg2 (Fig. 3D). The levels of tyrosine
phosphorylation of LAT and PLCg2 were also inhibited in a
concentration-dependent manner by quercetin.
Collagen-stimulated platelet activation via GPVI is therefore
inhibited by quercetin, but it was unclear whether quercetin
exerts effects at the top of the pathway alone or whether it has
effects at other locations in the GPVI signaling pathway.
Reports of the inhibitory effects of quercetin or related com-
pounds on a number of signaling molecules indicated that this
was a possibility [25]. The effect of quercetin on the enzymatic
activities of specific components of the pathways activated by
GPVI were therefore examined.
The kinase activities of the Src-family kinases Fyn and Lyn and
the tyrosine kinase Syk are inhibited by quercetin
The tyrosine phosphorylation of the FcR g-chain following
collagen binding to GPVI is mediated by the Src-family kinases
Fyn and Lyn [26,27]. This leads to the recruitment and activa-
Fig. 2. Collagen-stimulated platelet protein
tyrosine phosphorylation is inhibited by
quercetin. Platelets in the presence of EGTA
(1 mM) were incubated with quercetin or solvent
control for 5 min and then stimulated with
collagen (25mg mL1) for 90 s. Platelets were
lyzed and proteins separated by SDS–PAGE
under reducing conditions and immunoblotted to
detect protein phosphotyrosine residues. Data are
representative of three separate experiments.
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tion of the cytosolic tyrosine kinase Syk. These three proteins
were investigated for an inhibitory effect of quercetin on their
kinase activities (Fig. 4). Fyn and Lyn were immunoprecipitated
from platelets stimulated with collagen (25mg mL1) in the
presence and absence of quercetin and assayed for kinase
activity in vitro. As shown in Fig. 4Ai,Bi, the kinase activities
of Fyn and Lyn, respectively, were inhibited by quercetin in a
concentration-dependent manner. Quercetin was also seen to
inhibit the kinase activity of Syk (Fig. 4Ci) in a concentration-
dependent manner.
Since Fyn and Lyn are involved in initiating GPVI signaling,
our results suggest that quercetin may directly inhibit the
activity of Fyn and Lyn. We therefore examined the ability
of quercetin directly to inhibit these enzymes. This was
achieved by incubating immunoprecipitated Fyn or Lyn kinase
with quercetin before measuring kinase activity in vitro. The
kinase activities of Fyn and Lyn were seen to be inhibited
directly by quercetin in a concentration-dependent manner
(Fig. 4Aii,Bii, respectively). As is common with kinase inhibi-
tors, the direct inhibitory action of quercetin was more
potent than its effect on whole cells. The potential ability of
quercetin to inhibit Syk kinase activity directly was also ex-
amined in the same way as for Fyn and Lyn. Quercetin also
directly inhibited Syk (Fig. 4Cii) in a concentration-dependent
manner.
Quercetin inhibits collagen-stimulated PI 3-kinase
activity
PI 3-kinase plays a critical role in the activation of platelets and
is recruited to the phosphorylated FcR g-chain and LAT upon
activation of GPVI [5]. The effect of quercetin on PI 3-kinase
activity was therefore investigated in a similar format to that of
the other kinases (see above). Platelets were preincubated with
quercetin or solvent alone and then stimulated with collagen
(25mg mL1). PI 3-kinase was immunoprecipitated from plate-
let lysates and kinase activity was assayed in vitro using
phosphoinositide as substrate. As shown in Fig. 5A, quercetin
inhibited significantly collagen-induced PI 3-kinase activity in a
concentration dependent manner (P 0.005 for 125mM quer-
cetin). In a second series of experiments, the ability of quercetin
directly to inhibit PI 3-kinase isolated from platelets was
examined. Platelets were stimulated with collagen
(25mg mL1) before isolation of PI 3-kinase and determination
of kinase activity in the presence or absence of quercetin
(Fig. 5B). In these experiments quercetin significantly inhibited
PI 3-kinase activity directly (P 0.005 with 10, 50 and 150mM
quercetin) and with a higher potency than seen with preincuba-
tion of platelets with quercetin (Fig. 5A).
Discussion
A group of antioxidants of the flavonoid family has been shown
to inhibit platelet aggregation in vitro [15–17] and human
studies have also suggested that a diet high in flavonoids
may inhibit platelet aggregation in vivo [28]. Quercetin, a
Fig. 3. Quercetin inhibits the tyrosine phosphorylation of multiple
components of the GPVI signaling pathway. Platelets in the presence of
EGTA (1 mM) were incubated with quercetin or solvent control
for 5 min and then stimulated with collagen (25mg mL1) for 90 s. (A)
Platelet cell lysates were incubated with GST–Syk tandem SH2 domains
fusion protein for 2 h at 4 8C. Precipitated proteins were separated by
SDS–PAGE and immunoblotted to detect protein phosphotyrosine residues.
The low-molecular-weight band indicated has previously been
identified as the FcR g-chain. (B,C,D) Platelet lysates were incubated with
anti-Syk (LR), anti-LAT or anti-PLCg2, respectively, and protein
A-Sepharose (PAS) for 2 h at 4 8C. Precipitated proteins were
separated by SDS–PAGE and immunoblotted to detect phosphotyrosine
residues. Equivalent protein loading was verified by reprobing for
Syk, LAT or PLCg2. Data are representative of three separate
experiments.
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flavonoid that has received much attention in the area of
nutritional biology, has been shown to inhibit platelet aggrega-
tion in vitro [15], although a specific mechanism by which
this inhibition occurs has not been established. Reports have
indicated that a number of intracellular events associated with
the control of platelet activation and hemostasis are also
affected following treatment of platelets with quercetin. These
include inhibition of the generation of metabolites of arachi-
donic acid by cyclooxygenase and lipoxygenase [16,29], and
inhibition of calcium-dependent isoforms of protein kinase C
(PKC) [30].
Consistent with previous reports, quercetin was shown to
inhibit collagen-induced platelet aggregation in vitro in a con-
centration-dependent manner. This was also dependent on the
concentration of collagen used, with higher concentrations of
quercetin being required to overcome stimulation by higher
concentrations of collagen. All the IC50 values for quercetin
reported in this study are lower than those previously published
[15,16]. Discrepancies with published IC50 values are likely to
be a result of different experimental procedures and reagents. It
is particularly interesting to note that the IC50 values reported
here fall within or close to concentrations that may be present in
the plasma. Quercetin levels in blood plasma after ingestion of
certain forms of quercetin have been reported as high as 3mM
[31]. Therefore quercetin derived from the normal diet or
through supplementation may have an inhibitory effect on
platelet function in vivo.
Due to the potent inhibitory effect of quercetin on collagen-
stimulated platelet aggregation in comparison with other
agonists such as thrombin, the effect of quercetin on the
collagen-stimulated signaling pathway was examined. Querce-
tin was found to inhibit both collagen-stimulated protein
Fig. 4. The kinase activities of the Src-family kinases Fyn and Lyn, and the tyrosine kinase Syk are inhibited by quercetin. For experiments investigating the
effect of quercetin on kinase activity via the GPVI collagen activation pathway (i), washed platelets in the presence of EGTA (1 mM) were incubated
with quercetin or solvent control for 5 min and then stimulated with collagen (25mg mL1) for 90 s. Platelet cell lysates were then incubated with
anti-Fyn (A), anti-Lyn (B), or anti-Syk(LR) (C), and protein A-Sepharose (PAS) for 2 h at 4 8C. Immunoprecipitates were assayed for kinase activity as
described in Methods. For experiments investigating the direct effect of quercetin on kinase activity (ii), immunoprecipitates (as above) were
resuspended in kinase buffer with quercetin or solvent control and then assayed for kinase activity. For both experiments incorporation of 32P into the
immunoprecipitated protein was detected by phosphorimager. Immunoprecipitation was verified by reprobing for the appropriate antibody to ensure equal
loading. Data are representative of three separate experiments.
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tyrosine phosphorylation and collagen-stimulated calcium mo-
bilization from intracellular stores. These processes are both
essential for platelet activation and play a major role in platelet
aggregation [4,22], although this may be explained by inhibi-
tion of a range of signaling proteins that lie upstream of these
events.
We therefore investigated the effect of quercetin on specific
molecules of the collagen-stimulated activation signaling
pathway. Quercetin was found to inhibit tyrosine phosphoryla-
tion of the FcR g-chain and therefore appears to have an
inhibitory effect at the top of the collagen-stimulated activation
pathway. Tyrosine phosphorylation of the FcR g-chain is
thought to involve the activity of two Src-family kinases,
namely Fyn and Lyn [26,27]. We have also shown that quercetin
is able to inhibit the kinase activity of Fyn and Lyn in a
concentration-dependent manner, both via GPVI (in whole
cells) and directly. Consequently, quercetin is able to inhibit
collagen-stimulated tyrosine phosphorylation of the FcR
g-chain.
Since it has been suggested that quercetin inhibits a range of
signaling proteins, additional molecules further down the GPVI
collagen activation pathway were examined for the effect of
quercetin on their activation. Quercetin was shown to inhibit
both the tyrosine phosphorylation and the kinase activity of Syk,
although this is likely to be in part a consequence of the
inhibition of Fyn and Lyn, and thereby the signaling down-
stream of these. However, we also found that quercetin has a
direct inhibitory effect on Syk kinase activity. Tyrosine phos-
phorylation and activation of Syk is thought to lead to the
phosphorylation of tyrosine residues in the transmembrane
protein LAT and subsequently PLCg2, and this was also in-
hibited by quercetin. The recruitment and binding of PI 3-kinase
to tyrosine phosphorylated LAT is involved in the activation of
this enzyme and generation of 30-phosphorylated inositol phos-
pholipid second messengers. Quercetin was therefore also
suspected to have an inhibitory effect on the activation of PI
3-kinase. Indeed, the activity of PI 3-kinase was found to be
inhibited by quercetin, both via GPVI (in whole cells) and
directly. The direct effect of quercetin on PI 3-kinase activity is
consistent with a number of studies [25,32]. It has been
suggested that quercetin is ATP-competitive on PI 3-kinase
[32]. This is consistent with our observations for PI 3-kinase,
and also Fyn, Lyn and Syk, where the inhibitory action of
quercetin is more potent when incubated directly with isolated
kinases in comparison with its effect on these enzymes when
incubated with intact platelets where high ATP concentrations
are present. This effect may indicate a mechanism of action.
The potent ability of quercetin to inhibit platelet function,
compared with other dietary components that have been stu-
died, is likely to reflect its capacity to inhibit a wide range of
signaling enzymes involved in the activation process. We have
shown this to include tyrosine and lipid kinases, and evidence
from the literature suggests that this compound will also inhibit
serine/threonine kinases [25].
This study has concentrated on the effects of quercetin on
platelet signaling by an activation pathway that is absolutely
dependent on the activation of kinases. It is noteworthy that G
protein-coupled thrombin receptor-mediated activation of pla-
telets, which is less dependent on protein kinases, is less
sensitive to inhibition by quercetin. The inhibitory effect of
quercetin on thrombin-mediated activation is likely to be
because thrombin signaling also leads to activation of PI 3-
kinase. Therefore, although this dietary component appears to
be a relatively non-selective inhibitor of kinases, its effect on
platelet function depends on the activation pathway that is
stimulated.
The activation of platelets is associated with the generation of
reactive oxygen species which are believed to be involved in the
Fig. 5. Quercetin inhibits collagen-stimulated phosphoinositide (PI)
3-kinase activity. (A) Washed platelets in the presence of EGTA (1 mM)
were preincubated with quercetin or solvent control for 5 min and then
stimulated with collagen (25mg mL1) for 90 s. PI 3-kinase was
immunoprecipitated from platelet lysates and resuspended in kinase buffer
containing phosphoinositide vesicles and incubated for 20 min at 4 8C.
g-32P-ATP was then added and incubated for 10 min at 30 8C. Lipids were
extracted and separated by thin layer chromatography and incorporation
of 32P into the lipid product phosphoinositide 3,4,5-trisphosphate was
detected by phosphorimager. Data represent mean percentage 32P
incorporation compared with control as a measure of PI 3-kinase activity
(n¼ 3,	SEM, P 0.005). (B) The direct effect of quercetin on
PI 3-kinase activity was examined by incubating immunoprecipitates in
kinase buffer containing phosphoinositide vesicles and quercetin or solvent
control. Kinase activity was determined as above. Data represent mean
percentage 32P incorporation compared with control as a measure of
PI 3-kinase activity with direct inhibition by quercetin (n¼ 3,	 SEM,
P 0.005).
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regulation of platelet responses [33]. This is possibly through
the inhibition of protein phosphatases, although this is not fully
characterized. In this study we have not examined the possi-
bility that the antioxidant capacity of this molecule may play a
role in its inhibitory activity.
In summary, we have established in this study that the
potent inhibitory action of the dietary flavonoid quercetin on
platelet function is a result of the ability of this compound to
inhibit multiple components of collagen-stimulated signaling
pathways in platelets. The relationship between diet and
cardiovascular disease is complex, but the observations de-
scribed in this study may begin to address the beneficial effects
of a diet rich in flavonoids on the cardiovascular system. Further
work is required to determine whether quercetin may be
beneficial in the prevention of thrombosis, from diet or supple-
mentation.
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